Table 2. The list of clinical trials registered to United States National Library of Medicine (www.clinicaltrials.gov) for treatment of HCC patients using IRE.

Study title	Phase	Intervention/treatment	Patient	Status	Results	Identifier
A prospective, multi-center, clinical trial using IRE for the treatment of early-stage HCC	NA	Dev.: NanoKnife Low Energy Direct Current (LEDC) System	26	C	77% CR presented on 1 month biopsy-proven results	NCT01078415
A prospective clinical trial using IRE for the treatment of unresectable hepatic carcinoma (HC) close to the gallbladder	NA	Dev.: NanoKnife	30	R	No results posted	NCT02332551
HC in poor liver function: safety and efficacy of IRE	NA	Dev.: NanoKnife LEDC System	15	R	Frequent hypertension due to adrenal gland damage	NCT02352935
Comparison of immunological response after MWA and IRE of HCC	NA	Device: MWA, NanoKnife IRE	40	W	No results posted	NCT03040453
A prospective clinical trial using IRE for treatment of liver cancers	NA	Dev.: IRE System	18	C	No results posted	NCT02828865
Study of the contribution of automatic image fusion of a cone-beam CT volume with ultrasound during percutaneous ablation treatment of hepatic tumors	NA	Rad.: interact active tracker	60	R	No results posted	NCT04420026
IRE of unresectable liver tumors - a phase I study of safety and feasibility	NA	Proc.: IRE	15	R	No results posted	NCT04404647
Prospective evaluation of tumor response to cancer treatment therapies	–	Proc.: TACE, Y-90, MWA, IRE	10	T	No results posted	NCT02787954
Evaluation of tumor ablation effects by IRE for patients with malignant liver tumors	NA	Proc.: IRE	20	C	No results posted	NCT02010801

A, active; C, completed; R, recruiting; T, terminated; W, withdrawn; HCC, hepatocellular carcinoma; IRE, irreversible electroporation; MWA, microwave ablation; NA, not available; TACE, transarterial chemoembolization.